S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

BioXcel Therapeutics (BTAI) News Today

$2.75
+0.20 (+7.84%)
(As of 04/19/2024 ET)
SourceHeadline
MarketBeat logoBioXcel Therapeutics, Inc. (NASDAQ:BTAI) Receives Consensus Recommendation of "Hold" from Analysts
americanbankingnews.com - April 19 at 4:14 AM
MarketBeat logoQ1 2024 Earnings Estimate for BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Issued By HC Wainwright
americanbankingnews.com - April 19 at 1:48 AM
marketbeat.com logoQ1 2024 EPS Estimates for BioXcel Therapeutics, Inc. Lifted by HC Wainwright (NASDAQ:BTAI)
marketbeat.com - April 18 at 5:59 AM
MarketBeat logoResearch Analysts Offer Predictions for BioXcel Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:BTAI)
americanbankingnews.com - April 18 at 2:26 AM
investing.com logoBioXcel Therapeutics stock target cut, retains buy rating
investing.com - April 17 at 7:22 PM
marketbeat.com logoHC Wainwright Comments on BioXcel Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:BTAI)
marketbeat.com - April 17 at 5:55 PM
msn.com logoBioXcel Therapeutics (BTAI) Price Target Decreased by 9.82% to 10.71
msn.com - April 17 at 2:22 PM
markets.businessinsider.com logoBuy Rating Affirmed for Bioxcel Therapeutics Amid Strategic Clinical Trials and Regulatory Potential
markets.businessinsider.com - April 15 at 7:24 PM
marketbeat.com logoShort Interest in BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Drops By 20.7%
marketbeat.com - April 13 at 9:15 PM
investing.com logoBioXcel Therapeutics to begin phase 3 trial for Alzheimer's treatment
investing.com - April 12 at 12:56 AM
investing.com logoBioXcel Therapeutics CCO sells $2.6k in stock
investing.com - April 11 at 12:05 AM
uk.investing.com logoBioXcel Therapeutics CSO sells shares worth over $2.8k
uk.investing.com - April 10 at 2:03 PM
investing.com logoBioxcel Therapeutics exec sells over $400 in stock
investing.com - April 10 at 2:03 PM
investing.com logoBioXcel Therapeutics CEO sells shares worth over $13,000
investing.com - April 10 at 2:03 PM
finance.yahoo.com logoBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
finance.yahoo.com - April 10 at 9:03 AM
globenewswire.com logoBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer's Dementia
globenewswire.com - April 10 at 7:00 AM
insidertrades.com logoInsider Selling: BioXcel Therapeutics, Inc. (NASDAQ:BTAI) CEO Sells 5,268 Shares of Stock
insidertrades.com - April 9 at 4:48 AM
marketbeat.com logoShort Interest in BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Decreases By 20.9%
marketbeat.com - March 30 at 10:08 AM
globenewswire.com logoBioXcel Therapeutics Announces $25 Million Registered Direct Offering
globenewswire.com - March 25 at 7:00 AM
finance.yahoo.com logoBioXcel Therapeutics Full Year 2023 Earnings: Revenues Disappoint
finance.yahoo.com - March 24 at 9:16 AM
marketbeat.com logoBioXcel Therapeutics' (BTAI) "Buy" Rating Reaffirmed at HC Wainwright
marketbeat.com - March 18 at 5:32 PM
marketbeat.com logoBioXcel Therapeutics (NASDAQ:BTAI) Price Target Cut to $7.00 by Analysts at Canaccord Genuity Group
marketbeat.com - March 18 at 4:34 PM
markets.businessinsider.com logoBuy Rating Affirmed for BioXcel Therapeutics: FDA Pathway Clear for BXCL501 Expansion
markets.businessinsider.com - March 18 at 4:27 PM
au.news.yahoo.com logoTapeworm eggs found in brain of man with penchant for 'undercooked' bacon
au.news.yahoo.com - March 15 at 11:18 PM
markets.businessinsider.com logoBioXcel Gets European Patent For Sublingual Dexmedetomidine To Treat Agitation In Dementia Patients
markets.businessinsider.com - March 15 at 6:17 PM
markets.businessinsider.com logoBioxcel Therapeutics: Hold Rating Amid Financial and Operational Uncertainties
markets.businessinsider.com - March 15 at 8:16 AM
tmcnet.com logoBioXcel Therapeutics Announces European Patent Office's Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
tmcnet.com - March 15 at 8:16 AM
finance.yahoo.com logoBioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
finance.yahoo.com - March 15 at 8:16 AM
globenewswire.com logoBioXcel Therapeutics Announces European Patent Office's Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
globenewswire.com - March 15 at 7:00 AM
msn.com logoPetco CEO Ron Coughlin steps down, ex-BestBuy exec named as replacement
msn.com - March 15 at 1:30 AM
msn.com logoFDA approves first drug for serious liver disease
msn.com - March 15 at 1:30 AM
au.lifestyle.yahoo.com logoApple acquires AI startup specializing in overlooking manufacturing components
au.lifestyle.yahoo.com - March 15 at 1:30 AM
msn.com logoInfectious disease outbreak at major festival
msn.com - March 15 at 1:30 AM
au.news.yahoo.com logoTwo words health boss wants scrapped
au.news.yahoo.com - March 14 at 8:29 PM
au.news.yahoo.com logoSeven tips on how to lower your blood pressure, according to Doctor Hilary Jones
au.news.yahoo.com - March 14 at 3:28 PM
marketbeat.com logoShort Interest in BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Decreases By 46.8%
marketbeat.com - March 14 at 2:22 PM
seekingalpha.com logoBioXcel Therapeutics, Inc. (BTAI) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 14 at 10:28 AM
msn.com logoAs Hershey battles cocoa costs, chocolate lovers may help cool inflation
msn.com - March 14 at 5:27 AM
msn.com logoCovid patients wrongly issued with ‘do not resuscitate’ orders, watchdog finds
msn.com - March 14 at 5:27 AM
markets.businessinsider.com logoBuy Rating Affirmed for BioXcel Therapeutics Amid Label Expansion and Strong Clinical Prospects
markets.businessinsider.com - March 14 at 5:27 AM
finance.yahoo.com logoQ4 2023 BioXcel Therapeutics Inc Earnings Call
finance.yahoo.com - March 13 at 2:15 AM
markets.businessinsider.com logoHere's what Wall Street expects from BioXcel Therapeutics's earnings
markets.businessinsider.com - March 12 at 4:14 PM
globenewswire.com logoBioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
globenewswire.com - March 12 at 7:00 AM
marketbeat.com logoAdage Capital Partners GP L.L.C. Cuts Stock Position in BioXcel Therapeutics, Inc. (NASDAQ:BTAI)
marketbeat.com - March 12 at 5:54 AM
marketbeat.com logoFmr LLC Sells 1,672,720 Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI)
marketbeat.com - March 9 at 4:21 AM
uk.investing.com logoBioXcel Therapeutics Inc (BTAI)
uk.investing.com - March 7 at 7:49 PM
investorplace.com logo7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
investorplace.com - March 7 at 2:52 PM
marketbeat.com logoBioXcel Therapeutics (BTAI) Set to Announce Quarterly Earnings on Tuesday
marketbeat.com - March 5 at 4:52 AM
globenewswire.com logoBioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
globenewswire.com - March 1 at 7:00 AM
finance.yahoo.com logoBTAI Mar 2024 1.500 call
finance.yahoo.com - February 26 at 8:32 AM
Get BioXcel Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTAI and its competitors with MarketBeat's FREE daily newsletter.

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

BTAI Media Mentions By Week

BTAI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BTAI
News Sentiment

0.65

0.52

Average
Medical
News Sentiment

BTAI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BTAI Articles
This Week

14

5

BTAI Articles
Average Week

Get BioXcel Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTAI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BTAI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners